Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
411
-431
-51% -$199K ﹤0.01% 978
2026
Q1
$404K Buy
+842
New +$431K ﹤0.01% 681
2024
Q4
Sell
-811
Closed -$271K 771
2024
Q3
$271K Buy
+811
New +$308K 0.01% 402

Other funds holding MEDP

Marex Group's MEDP Position: Q2 2026 in Review

Marex Group reduced its Medpace (MEDP) stake by 51% in Q2 2026, selling an estimated $199K and leaving 411 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

Marex Group first reported a position in MEDP in Q3 2024 and has held it in 3 quarters since. The position peaked at $404K in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Marex Group held 411 shares of Medpace worth $218K as of Q2 2026.
  • Marex Group sold 431 Medpace shares in Q2 2026, an estimated $199K.
  • Medpace made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #978 holding.
  • Marex Group first reported a position in Medpace in Q3 2024 and has held it in 3 quarters since.
  • Marex Group's Medpace position peaked at $404K in Q1 2026.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.